• About
    • Our Team
    • Our Partners
    • Our Work
  • Tools
    • Case Definitions
    • Vaccine Safety Templates
    • Translations
    • Benefit-Risk Assessment Module
  • Resources
    • News
    • Newsletter
    • Safety by Numbers
    • Webinars
  • Training
    • DSMB Training
    • CDC Training​
    • Vaccine Courses
  • SPEAC
Menu
  • About
    • Our Team
    • Our Partners
    • Our Work
  • Tools
    • Case Definitions
    • Vaccine Safety Templates
    • Translations
    • Benefit-Risk Assessment Module
  • Resources
    • News
    • Newsletter
    • Safety by Numbers
    • Webinars
  • Training
    • DSMB Training
    • CDC Training​
    • Vaccine Courses
  • SPEAC
MPOX
JOIN
Posted on September 3, 2024

Lessons Learned from Vaccine Safety Surveillance Efforts

Much has been learned about the need for vaccine safety surveillance through COVAX and other recent collaborative efforts. Here, w...
Read More
Posted on July 31, 2024September 9, 2024

Dr. Punnee Pitisuttithum: Engaging community in active vaccine safety surveillance

A member of both Brighton Collaboration and the Safety Platform for Emergency vACcines project’s Meta-DSMB, Dr. Punnee Pitis...
Read More
Posted on July 22, 2024July 22, 2024

Request for Review: Vaccine Safety Template – IDT Bio Manuscript

The proposed IDT Modified Vaccinia virus Ankara viral vector vaccine manuscript is ready for peer review. The Brighton Collaborati...
Read More
Posted on July 2, 2024July 2, 2024

Request for Review: Vaccine Safety Template for Clover COVID-19 recombinant protein vaccine

The proposed Clover COVID-19 recombinant protein vaccine manuscript is ready for peer review. The Brighton Collaboration BRAVATO (...
Read More
Posted on May 30, 2024May 30, 2024

Ensuring the safety of dengue vaccines: Alejandro Cravioto brings international expertise to the Pan-American Advisory Committee on Vaccine Safety

The World Health Organization (WHO) has reported a ten-fold increase in dengue cases over the past twenty years. Today, nearly 4 b...
Read More
Posted on March 22, 2024March 22, 2024

Dr. Eileen Farnon joins Brighton Collaboration as Research Director

The Task Force for Global Health welcomes Dr. Eileen Farnon as Brighton Collaboration’s new Research Director. Dr. Farnon, w...
Read More
Posted on March 11, 2024March 15, 2024

Lessons Learned and Key Recommendations from the COVAX Vaccine Safety Working Group

The Vaccine Safety Working Group (VSWG) of COVAX was formed in November 2020 with representatives and consultants representing mul...
Read More
Posted on February 21, 2024April 15, 2024

COVID-19 Safety Studies project offers evidence to support increasing active vaccine safety surveillance in low- and middle-income countries

Vaccine safety data can help build public confidence in vaccines by communicating that the benefits outweigh the risks of immuniza...
Read More
Posted on February 19, 2024February 21, 2024

99 Million People Included in Largest Global Vaccine Safety Study

Global Vaccine Data Network utilises vast data sets to detect potential vaccine safety signals 19 February 2024—The Global Vacc...
Read More
Posted on February 5, 2024

Request for Review: Standardized template with key considerations for a benefit/risk assessment for the Comirnaty COVID-19 mRNA vaccine

The proposed mRNA BioNTech/Comirnaty manuscript is ready for peer review. The Brighton Collaboration BRAVATO (Benefit-Risk Asses...
Read More
1 2 3 4 Next page

Recent Posts

  • Safety by Numbers – February 2025February 19, 2025
  • Brighton Collaboration News — Sept 2024September 9, 2024
  • Lessons Learned from Vaccine Safety Surveillance EffortsSeptember 3, 2024
  • Comirnaty COVID-19 mRNA vaccine: standardized template with key considerations for a benefit-risk assessmentAugust 27, 2024
  • Safety by Numbers – August 2024August 14, 2024

Email:
bc-coordinator@taskforce.org

Address:
The Task Force for Global Health,
330 W. Ponce de Leon Ave.
Decatur, GA 30030

  • Case Definitions
  • Safety Templates
  • Covid-19
  • Trusted Sources
Linkedin

© Brighton Collaboration  2023. All rights reserved.

  • Disclaimer and Privacy Policy